Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
102 rows where has_known_aptamer = 1, surface_class = "A_surface" and tier = "Tier 1.5" sorted by evidence_priority descending
This data as json, CSV (advanced)
Suggested facets: pdb_count_total, aptamer_count_pubmed
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P21359 | NF1 | Neurofibromin | Tier 1.5 | 0.965 | 1 | A_surface | 26 | 87.19 | 1 | 0 | 1 | 2 | 32980430, 22617876 | 1 | neurofibromatosis type 1 | 0.8844735398780649 | ||
| P00813 | ADA | Adenosine deaminase | Tier 1.5 | 0.957 | 1 | A_surface | 2 | 96.56 | 0 | 0 | 1 | 72 | 42012076, 41877526, 41762796, 41635914, 40403280, 40189053, 39856849, 39847085, 36796307, 33998617, 32043202, 30876536, 30060448, 27589406, 26606306, 25597304, 25521724, 25360869, 24976151, 24893272, 24682016, 24035856, 23462984, 23202335, 23037591, 22944024, 22613226, 41910181, 41791686, 41267360, 39673485, 39396299, 38583236, 36855421, 34241023, 33147453, 32546280, 30926472, 26605646, 24624989, 23373863, 22543727, 20345118, 19381549, 19378312, 18293985, 17440909, 17000903, 16856187, 16619330 | 1 | Severe combined immunodeficiency due to adenosine deaminase deficiency | 0.8556816060494579 | ||
| P36888 | FLT3 | Receptor-type tyrosine-protein kinase FLT3 | Tier 1.5 | 0.949 | 1 | A_surface | 11 | 75.94 | 0 | 0 | 1 | 6 | 41733039, 34364920, 31434881, 30237882, 29299123, 22411871 | 1 | acute myeloid leukemia | 0.8313389209288576 | ||
| P16234 | PDGFRA | Platelet-derived growth factor receptor alpha | Tier 1.5 | 0.945 | 1 | A_surface | 14 | 72.69 | 1 | 0 | 1 | 4 | 33334063, 32127469, 28010895, 30594071 | 1 | gastrointestinal stromal tumor | 0.8167494524079806 | ||
| P04626 | ERBB2 | Receptor tyrosine-protein kinase erbB-2 | Tier 1.5 | 0.934 | 1 | A_surface | 63 | 74.0 | 0 | 0 | 1 | 119 | 41836728, 41744190, 41540559, 41494763, 41413339, 41321156, 41297941, 40851486, 40761795, 40494827, 40403699, 40382399, 40223744, 40220375, 40120226, 40080161, 40056884, 39873777, 39809083, 39756158, 39748051, 39643321, 39609809, 39539244, 39263860, 39233482, 39177424, 38901393, 38813974, 38789508, 38693181, 38679242, 38604040, 38409854, 38066021, 37729138, 37659641, 37591183, 37522239, 37392577, 37038354, 36272296, 36255496, 36001395, 35504229, 34952586, 34476602, 34236165, 33876310, 33627408 | 1 | non-small cell lung carcinoma | 0.7789523142843545 | ||
| P15529 | CD46 | Membrane cofactor protein | Tier 1.5 | 0.934 | 1 | A_surface | 7 | 82.12 | 1 | 0 | 1 | 9 | 35114109, 34248841, 31761039, 31077760, 27734375, 19915929, 17046833, 11084032 | 1 | atypical hemolytic-uremic syndrome with MCP/CD46 anomaly | 0.7798469882597787 | ||
| P24394 | IL4R | Interleukin-4 receptor subunit alpha | Tier 1.5 | 0.923 | 1 | A_surface | 10 | 54.75 | 0 | 0 | 1 | 3 | 32751068, 27819142, 22282665 | 1 | asthma | 0.742115080702623 | ||
| P25445 | FAS | Tumor necrosis factor receptor superfamily member 6 | Tier 1.5 | 0.921 | 1 | A_surface | 7 | 77.88 | 1 | 0 | 1 | 17 | 40784034, 39897575, 37458448, 36908619, 35402075, 32270033, 31436946, 30594071, 30417194, 30339905, 26318819, 23980164, 23511245, 18997060, 18956014, 16729304, 16581027 | 1 | autoimmune lymphoproliferative syndrome type 1 | 0.7377210386590284 | ||
| P16671 | CD36 | Platelet glycoprotein 4 | Tier 1.5 | 0.921 | 1 | A_surface | 1 | 93.94 | 0 | 0 | 1 | 6 | 41713143, 41140242, 39762152, 33596054, 33291667, 31904170 | 1 | platelet-type bleeding disorder 10 | 0.7360571429413174 | ||
| P09758 | TACSTD2 | Tumor-associated calcium signal transducer 2 | Tier 1.5 | 0.919 | 1 | A_surface | 7 | 82.69 | 0 | 0 | 1 | 4 | 41384307, 41241473, 40050871, 39250993 | 1 | gelatinous drop-like corneal dystrophy | 0.7293087728162646 | ||
| P08637 | FCGR3A | Low affinity immunoglobulin gamma Fc region receptor III-A | Tier 1.5 | 0.912 | 1 | A_surface | 15 | 85.69 | 0 | 0 | 1 | 2 | 41249026, 21531729 | 1 | autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity | 0.7061437347032623 | ||
| P02786 | TFRC | Transferrin receptor protein 1 | Tier 1.5 | 0.887 | 1 | A_surface | 22 | 86.69 | 1 | 0 | 1 | 3 | 39831311, 29046922, 32527800 | 1 | TFRC-related combined immunodeficiency | 0.623449899069336 | ||
| P15260 | IFNGR1 | Interferon gamma receptor 1 | Tier 1.5 | 0.862 | 1 | A_surface | 5 | 66.0 | 0 | 0 | 1 | 2 | 33667716 | 1 | disseminated atypical mycobacterial infection | 0.5414012388034828 | ||
| P21926 | CD9 | CD9 antigen | Tier 1.5 | 0.858 | 1 | A_surface | 5 | 88.56 | 0 | 0 | 1 | 17 | 41999228, 41625383, 40618375, 39266887, 38866706, 38057814, 37585601, 37351166, 37019008, 36704890, 34647460, 34505435, 33304477, 32730952, 32207293, 28959386 | 1 | diphtheria | 0.5261379875719714 | ||
| P13591 | NCAM1 | Neural cell adhesion molecule 1 | Tier 1.5 | 0.852 | 1 | A_surface | 7 | 79.5 | 0 | 0 | 1 | 1 | 36649818 | 1 | smoking initiation | 0.5071020926446286 | ||
| Q92633 | LPAR1 | Lysophosphatidic acid receptor 1 | Tier 1.5 | 0.843 | 1 | A_surface | 16 | 83.62 | 1 | 0 | 1 | 1 | 32065590 | 1 | Epiretinal membrane | 0.4757255248053499 | ||
| Q9P121 | NTM | Neurotrimin | Tier 1.5 | 0.824 | 1 | A_surface | 2 | 82.38 | 0 | 0 | 1 | 2 | 35699468, 26194558 | 1 | smoking initiation | 0.41382172436739945 | ||
| Q14242 | SELPLG | P-selectin glycoprotein ligand 1 | Tier 1.5 | 0.82 | 1 | A_surface | 1 | 50.38 | 0 | 0 | 1 | 1 | 25979951 | 1 | glaucoma | 0.40058604767334977 | ||
| P08571 | CD14 | Monocyte differentiation antigen CD14 | Tier 1.5 | 0.818 | 1 | A_surface | 1 | 84.75 | 0 | 0 | 1 | 14 | 41636061, 41542672, 41140242, 38477735, 38280803, 37162508, 36716100, 36475636, 32589412, 32515246, 30900705, 30563044, 25483705, 12498773 | 1 | dengue disease | 0.39219972762611355 | ||
| P31785 | IL2RG | Cytokine receptor common subunit gamma | Tier 1.5 | 0.804 | 1 | A_surface | 14 | 75.5 | 1 | 0 | 1 | 2 | 30800133, 33869115 | 0 | gamma chain deficiency | 0.8469997000418428 | ||
| Q5ZPR3 | CD276 | CD276 antigen | Tier 1.5 | 0.804 | 1 | A_surface | 3 | 83.31 | 1 | 0 | 1 | 1 | 38866941 | 1 | response to statin | 0.3471917147958521 | ||
| P08100 | RHO | Rhodopsin | Tier 1.5 | 0.804 | 1 | A_surface | 4 | 88.75 | 1 | 0 | 1 | 45 | 41963275, 41924874, 41636061, 40808302, 40642289, 40330320, 40045571, 39863313, 39788632, 38070612, 37191882, 36705086, 36696850, 36095194, 36049339, 35622174, 34709779, 34471566, 32696702, 32479610, 32319623, 32119944, 31737572, 31588238, 31535128, 29570714, 29281176, 28648779, 27893356, 25645980, 23757206, 23701883, 25033804, 22689339, 22302221, 22121695, 19766091, 19389625, 16419035, 12123800, 8743323, 7678562, 19188685, 18230760 | 0 | retinitis pigmentosa | 0.8481942240861982 | ||
| O95342 | ABCB11 | Bile salt export pump | Tier 1.5 | 0.801 | 1 | A_surface | 8 | 83.12 | 1 | 0 | 1 | 1 | 36313979 | 0 | progressive familial intrahepatic cholestasis type 2 | 0.8372060401943777 | ||
| P10912 | GHR | Growth hormone receptor | Tier 1.5 | 0.799 | 1 | A_surface | 9 | 58.69 | 0 | 0 | 1 | 5 | 38811951, 38477735, 31603904 | 0 | Laron syndrome | 0.8304020079647765 | ||
| Q13308 | PTK7 | Inactive tyrosine-protein kinase 7 | Tier 1.5 | 0.796 | 1 | A_surface | 1 | 82.69 | 0 | 0 | 1 | 110 | 41949051, 41786503, 41782379, 41780252, 41473803, 41172349, 41097888, 41065179, 41047832, 40987771, 40652441, 40618375, 40556592, 40488675, 40479736, 40415219, 40388621, 40274545, 40033943, 39933564, 39583320, 39468753, 39405917, 39315658, 39226482, 39211579, 39161311, 39127174, 38985770, 38922365, 38889444, 38773263, 38708542, 38695582, 38642044, 38466380, 38359901, 38148412, 38064592, 37974961, 37480788, 37473438, 37458448, 37247456, 37105082, 37003060, 36765879, 36722904, 36722696, 36471380 | 1 | neurodegenerative disease | 0.3194172724024113 | ||
| P16410 | CTLA4 | Cytotoxic T-lymphocyte protein 4 | Tier 1.5 | 0.787 | 1 | A_surface | 22 | 80.12 | 0 | 0 | 1 | 26 | 41907643, 40972397, 40870970, 40811947, 40536609, 39417693, 38473398, 38158454, 36966395, 36831533, 36603108, 36015348, 33970170, 32929022, 32840510, 32280743, 32024070, 31405808, 28918052, 28082399, 26030229, 25565435, 24892807, 23460536, 23460531, 14612549 | 0 | autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency | 0.7906408646569979 | ||
| P08648 | ITGA5 | Integrin alpha-5 | Tier 1.5 | 0.785 | 1 | A_surface | 14 | 85.25 | 1 | 0 | 1 | 2 | 32174798, 38258032 | 1 | skin disease | 0.28465651599598124 | ||
| P32942 | ICAM3 | Intercellular adhesion molecule 3 | Tier 1.5 | 0.785 | 1 | A_surface | 1 | 87.12 | 0 | 0 | 1 | 3 | 40650261, 34730968, 17660953 | 1 | lymphatic system disease | 0.28331776251399693 | ||
| Q96MS0 | ROBO3 | Roundabout homolog 3 | Tier 1.5 | 0.784 | 1 | A_surface | 3 | 63.69 | 0 | 0 | 1 | 2 | 32369590 | 0 | horizontal gaze palsy with progressive scoliosis | 0.7813306356858872 | ||
| P51654 | GPC3 | Glypican-3 | Tier 1.5 | 0.779 | 1 | A_surface | 4 | 75.06 | 1 | 0 | 1 | 65 | 42083729, 41790019, 41653459, 41045695, 40825648, 40722645, 39998646, 39874791, 39608318, 39427046, 38910291, 38787447, 38621313, 38368644, 37665421, 36903516, 36457288, 36317566, 36072763, 35788872, 35699181, 35477501, 35051745, 34974867, 34306031, 33254049, 33080969, 32356075, 30347351, 30122918, 29675356, 29605994, 29277631, 27601357, 28263753 | 0 | Simpson-Golabi-Behmel syndrome type 1 | 0.762708583613362 | ||
| P20023 | CR2 | Complement receptor type 2 | Tier 1.5 | 0.776 | 1 | A_surface | 9 | 74.94 | 1 | 0 | 1 | 1 | 33235290 | 0 | immunodeficiency, common variable, 7 | 0.7543125403898414 | ||
| P40126 | DCT | L-dopachrome tautomerase | Tier 1.5 | 0.774 | 1 | A_surface | 1 | 89.12 | 0 | 0 | 1 | 1 | 27245069 | 0 | oculocutaneous albinism type 8 | 0.7468868816172217 | ||
| P08887 | IL6R | Interleukin-6 receptor subunit alpha | Tier 1.5 | 0.768 | 1 | A_surface | 10 | 77.88 | 1 | 0 | 1 | 18 | 40853309, 38152968, 37034659, 36579647, 35890412, 33590853, 33340765, 32515246, 29211023, 28929152, 26552813, 26383776, 24481022, 24440854, 23235494, 22503683, 22258147, 22094809 | 0 | rheumatoid arthritis | 0.7269057706798291 | ||
| Q00975 | CACNA1B | Voltage-dependent N-type calcium channel subunit alpha-1B | Tier 1.5 | 0.767 | 1 | A_surface | 7 | 59.91 | 1 | 0 | 1 | 2 | 31118475, 25782368 | 0 | Seizure | 0.7217241968702018 | ||
| P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | Tier 1.5 | 0.761 | 1 | A_surface | 8 | 78.19 | 0 | 0 | 1 | 2 | 38487531, 36979667 | 1 | progressive supranuclear palsy | 0.2036023725502463 | ||
| P48023 | FASLG | Tumor necrosis factor ligand superfamily member 6 | Tier 1.5 | 0.76 | 1 | A_surface | 3 | 80.19 | 0 | 0 | 1 | 1 | 16581027 | 0 | autoimmune lymphoproliferative syndrome type 1 | 0.6984292519156657 | ||
| P15391 | CD19 | B-lymphocyte antigen CD19 | Tier 1.5 | 0.755 | 1 | A_surface | 4 | 62.22 | 1 | 0 | 1 | 13 | 41079126, 40652441, 38661725, 38148412, 36095289, 35829681, 34680368, 34364920, 32401486, 31912987, 29928472, 21127492 | 0 | immunodeficiency, common variable, 3 | 0.6821072538733047 | ||
| P32970 | CD70 | CD70 antigen | Tier 1.5 | 0.75 | 1 | A_surface | 1 | 83.19 | 0 | 0 | 1 | 1 | 30609550 | 0 | severe combined immunodeficiency due to CD70 deficiency | 0.6651491980619259 | ||
| Q96RJ3 | TNFRSF13C | Tumor necrosis factor receptor superfamily member 13C | Tier 1.5 | 0.748 | 1 | A_surface | 8 | 63.03 | 1 | 0 | 1 | 1 | 23470998 | 0 | immunodeficiency, common variable, 4 | 0.660711678987284 | ||
| Q9HCK4 | ROBO2 | Roundabout homolog 2 | Tier 1.5 | 0.744 | 1 | A_surface | 6 | 67.38 | 0 | 0 | 1 | 2 | 40616090, 31640794 | 0 | familial vesicoureteral reflux | 0.6460375744556555 | ||
| Q8NER1 | TRPV1 | Transient receptor potential cation channel subfamily V member 1 | Tier 1.5 | 0.738 | 1 | A_surface | 8 | 71.94 | 1 | 0 | 1 | 2 | 40855286, 28604222 | 0 | migraine disorder | 0.6269329225883602 | ||
| P42658 | DPP6 | A-type potassium channel modulatory protein DPP6 | Tier 1.5 | 0.737 | 1 | A_surface | 8 | 86.69 | 1 | 0 | 1 | 1 | 41313574 | 0 | Autosomal dominant microcephaly | 0.6225938492787458 | ||
| P01876 | IGHA1 | Immunoglobulin heavy constant alpha 1 | Tier 1.5 | 0.736 | 1 | A_surface | 14 | 81.88 | 1 | 0 | 1 | 2 | 37325361 | 1 | IGA glomerulonephritis | 0.12053726815801102 | ||
| Q8N126 | CADM3 | Cell adhesion molecule 3 | Tier 1.5 | 0.735 | 1 | A_surface | 1 | 84.38 | 0 | 0 | 1 | 2 | 39263947 | 0 | Charcot-Marie-Tooth disease, axonal, type 2FF | 0.6157861516342734 | ||
| P01877 | IGHA2 | Immunoglobulin heavy constant alpha 2 | Tier 1.5 | 0.726 | 1 | A_surface | 4 | 83.0 | 1 | 0 | 1 | 2 | 37325361 | 1 | Chronic mucocutaneous candidosis | 0.08794784007807564 | ||
| P21709 | EPHA1 | Ephrin type-A receptor 1 | Tier 1.5 | 0.724 | 1 | A_surface | 4 | 80.38 | 0 | 0 | 1 | 4 | 35283197, 24629635, 41325160 | 0 | Alzheimer disease | 0.5784090512493305 | ||
| P31358 | CD52 | CAMPATH-1 antigen | Tier 1.5 | 0.723 | 1 | A_surface | 1 | 67.19 | 0 | 0 | 1 | 1 | 39865939 | 0 | chronic lymphocytic leukemia | 0.5770414699711784 | ||
| P18627 | LAG3 | Lymphocyte activation gene 3 protein | Tier 1.5 | 0.72 | 1 | A_surface | 6 | 78.38 | 1 | 0 | 1 | 6 | 40761795, 38158454, 36603108, 28934318 | 0 | melanoma | 0.5672649687930189 | ||
| P55259 | GP2 | Pancreatic secretory granule membrane major glycoprotein GP2 | Tier 1.5 | 0.707 | 1 | A_surface | 4 | 78.62 | 1 | 0 | 1 | 3 | 36902059, 25483705, 24334484 | 0 | type 2 diabetes mellitus | 0.5235291484788168 | ||
| O43653 | PSCA | Prostate stem cell antigen | Tier 1.5 | 0.706 | 1 | A_surface | 1 | 81.31 | 0 | 0 | 1 | 2 | 41911185 | 0 | duodenal ulcer | 0.5197329863180171 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;